Display options
Cite
Kurukulaaratchy RJ, Rupani H, Fong WCG, et al. A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. J Inflamm Res. 2021;14:5183-5185doi: 10.2147/JIR.S341547.
Kurukulaaratchy, R. J., Rupani, H., Fong, W. C. G., & Kyyaly, A. (2021). A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. Journal of inflammation research, 145183-5185. https://doi.org/10.2147/JIR.S341547
Kurukulaaratchy, Ramesh J, et al. "A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]." Journal of inflammation research vol. 14 (2021): 5183-5185. doi: https://doi.org/10.2147/JIR.S341547
Kurukulaaratchy RJ, Rupani H, Fong WCG, Kyyaly A. A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]. J Inflamm Res. 2021 Oct 08;14:5183-5185. doi: 10.2147/JIR.S341547. eCollection 2021. PMID: 34675596; PMCID: PMC8517631.
Copy Download .nbib Format: NLM
Share it on

J Inflamm Res. 2021 Oct 08;14:5183-5185. doi: 10.2147/JIR.S341547. eCollection 2021.

A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter].

Journal of inflammation research

Ramesh J Kurukulaaratchy, Hitasha Rupani, Wei Chern Gavin Fong, Aref Kyyaly

Affiliations

  1. Department of Respiratory Medicine, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
  2. Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
  3. David Hide Asthma and Allergy Research Centre, Isle of Wight NHS Trust, Isle of Wight, UK.
  4. NIHR Biomedical Research Centre, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.

PMID: 34675596 PMCID: PMC8517631 DOI: 10.2147/JIR.S341547

[No abstract available.]

Conflict of interest statement

HR reports speaker and consultancy fees from AstraZeneca, GlaxoSmithKline, Teva, and Novartis and research grant funding from GlaxoSmithKline. WCGF reports ownership of AstraZeneca, GlaxoSmithKline An

References

  1. Am J Respir Crit Care Med. 2012 Sep 15;186(6):501-7 - PubMed
  2. Pulm Pharmacol Ther. 2009 Dec;22(6):580-6 - PubMed
  3. J Clin Med. 2017 Nov 29;6(12): - PubMed
  4. J Inflamm Res. 2021 Sep 02;14:4371-4397 - PubMed
  5. Ann Allergy. 1985 Apr;54(4):294-6 - PubMed
  6. Adv Ther. 2020 May;37(5):1737-1753 - PubMed
  7. Int J Chron Obstruct Pulmon Dis. 2016 Jun 16;11:1297-306 - PubMed
  8. Respir Med. 2018 Feb;135:22-28 - PubMed
  9. J Inflamm Res. 2021 Sep 14;14:4603-4604 - PubMed
  10. J Asthma. 2020 May;57(5):505-509 - PubMed
  11. Lancet. 2017 Aug 12;390(10095):659-668 - PubMed
  12. Nat Commun. 2021 Jan 11;12(1):249 - PubMed
  13. Emerg Med J. 2002 Nov;19(6):594-5 - PubMed
  14. Eur Respir J. 2016 Feb;47(2):410-9 - PubMed
  15. J Allergy Clin Immunol Pract. 2021 Sep 14;: - PubMed
  16. Eur Respir J. 2007 Oct;30(4):653-61 - PubMed
  17. Cochrane Database Syst Rev. 2019 May 20;5:CD001287 - PubMed

Publication Types